Introduction
Extremely sensitive and accurate clinical measurements of biomarkers for the early detection and monitoring of cancer pose a formidable challenge. 1 Immunoassays are chemical tests used to detect or quantify a specific substance in biological fluids based on an immunological reaction. 2 Some more sophisticated analytical devices for immunoassays, such as surface plasmon resonance, quartz crystal microbalance, optical detection methods including fluorescence and chemiluminescence, and electrochemical method, have been studied on the basis of various signal-generation principles from complex interaction between antibody and antigen. 3 Among these methods, electrochemical immunoassay has attracted considered attention due to its intrinsic advantages, such as good portability, low cost, simple instrumentation, and high sensitivity. 4 In the electrochemical immunoassay, the on-line amplification of a detectable signal is extremely important to acquire high sensitivity. [5] [6] [7] Although the antigen-antibody reaction by itself can cause a change of the electrochemical signal to some extent, it is very minor. Enzyme labels are usually used for the amplification of a detectable signal. However, an enzyme-based electrochemical immunoassay is susceptible to interference and changes in the assay conditions during the signal generation stage. 6 An alternative immunosensing strategy is to combine an electrochemical principle with a non-enzyme-based electrocatalytic reaction for the signal amplification. In contrast, the emergence of nanotechnology opens a new horizon for the use of nanomaterial labeling for signal amplification. 8 Various nanostructure-based labeling probes have been reported for the development of an electrochemical immunoassay, e.g. multienzyme-DNA labeling, 9 graphene-silver hybrid nanostructure, 10 and magnetic bead. 11 By incorporation with the nanomaterial, the electrochemical immunoassay has shown great promise for the diagnosis of trace biomolecule with high sensitivity. 12 The graphene nanostructure, a thin elongated strip of sp 2 bonded carbon atoms, has attracted increasing attention. 13 Owing to its high surface areas, high aspect rations, and interesting electronic properties, the graphene nanostructure has become a promising candidate for applications in composite nanomaterials, field-effect transistors, transparent electrodes, hydrogen storage media, and other semiconductor devices. 14 A new and enzyme-free electrochemical immunoassay protocol was developed for the sensitive electronic monitoring of neuron-specific enolase (NSE) on a monoclonal mouse anti-human NSE antibody (mAb)-modified glassy carbon electrode, using guanine-decorated graphene nanostructures (GGN) as nanotags. To construct such an enzyme-free immunoassay format, guanine and polyclonal rabbit anti-human NSE antibody (pAb) were co-immobilized on the graphene nanostructures through the carbodiimide coupling. Based on a sandwich-type immunoassay mode, the assay was carried out in 0.1 M pH 7.4 PBS containing 5 μM Ru(bpy)3 2+ through the catalytic oxidation of Ru(bpy)3 2+ toward the guanine on the GGN. The presence of graphene nanostructures increased the immobilized amount of guanine, thus amplifying a detectable electronic signal. The covalent conjugation of guanine and pAb on the GGN resulted in a good repeatability and intermediate reproducibility down to 9.5%. Under optimal conditions, the dynamic concentration range of the developed immunoassay spanned from 0.005 to 80 ng mL -1 NSE with a detection limit of 1.0 pg mL -1 at the 3Sblank level. In addition, the methodology was evaluated by assaying the spiking serum samples, and the relative standard deviation (RSD) between the electrochemical immunoassay and a commercialized enzyme-linked immunosorbent assay (ELISA) were 2.8 -7.0%.
Keywords Guanine-decorated graphene nanostructures, bioelectrocatalytic reaction, neuron-specific enolase, electrochemical immunosensor in the components of DNA, has been commonly used for labelfree DNA sensing and protein assay. 16 The two variants for electrode oxidation on an electrode surface are direct oxidation on the electrode surface and mediator-induced guanine oxidation. 17 It has been reported that graphene nanostructures can strongly bind single-stranded DNA, such as aptamer and nucleobase, as a result of the hydrophobic and π-stacking interaction between the nucleobase and graphene, 18 thus causing the simultaneous conjugation of many guanine nucleobases on the graphene nanostructures. Since the electron-transfer kinetic from nucleic acid to the base electrode is poor, the signal from direct guanine oxidation is generally low when guanine acts as an electroactive reporter. 19 Ru(bpy) 3+/2+ , a mediator acted as a catalyst facilitating the guanine oxidation, has been applied in the bioassays. 20 Ropp and Thorp found that the nucleobase 8-oxo-guanine could be selectively oxidized by the redox catalyst Ru(bpy)3 3+/2+
(bpy = 2,2′-bipyridine) with current enhancement in the presence of native guanine. 21 Proposed mechanisms involve the interaction of guanine radicals with Ru 3+ to generate the Ru· 2+ excited state and the reduction of Ru 2+ to Ru + by the guanine radicals, followed by the annihilation of Ru 3+ and Ru + . 22 Guanine radicals can be formed upon one-electron oxidation, either via electrode processes or by reacting with Ru 3+ . Neuron-specific enolase (NSE) is a substance that has been detected in patients with certain tumors, namely neuroblastoma, small-cell lung cancer, and medullary thyroid cancer. 23 Herein we report on the proof-of-concept of a new and enzyme-free electrochemical immunosensing protocol for the determination of NSE, coupling with the bioelectrocatalytic reaction of the guanine on the graphene nanostructures in the presence of Ru(bpy)3
2+
. The detectable signal is amplified by coupling with a dual amplification mechanism resulting from multiple guanine-functionalized graphene nanostructures and Ru(bpy) 3+ -induced catalytic oxidation of guanine. The aim of this work is to develop an enzyme-free and in situ amplified electrochemical immunoassay strategy with sensitivity enhancement for the determination of low-abundance proteins.
Experimental

Reagents and chemicals
Polyclonal rabbit anti-human NSE antibody (pAb), monoclonal mouse anti-human NSE antibody (mAb) and NSE standards with various concentrations were purchased from Beijing Biosynthesis Biotechnology Co., Ltd. (Beijing, China). Bovine serum albumin (BSA), N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were obtained from Sigma-Aldrich (USA). β-Cyclodextrin (CD) was purchased from Sinopharm Chemical Research Co., Ltd. (Shanghai, China). Guanine was purchased from Sinopharm Chemical Reseacrh Co., Ltd. All other reagents were of analytical grade, and were used without further purification. Ultrapure water obtained from a Millipore water purification system (≥ 18 MΩ, Milli-Q, Millipore) was used in all runs; a 0.1 M phosphate buffer solution (PBS, pH 7.4) was prepared by adding 12.2 g K2HPO4, 1.36 g KH2PO4, and 8.5 g KCl into 1000 mL of deionized water.
Instrumentation
All electrochemical measurements were performed with a CHI 660 electrochemical workstation (Shanghai CH Instruments Inc., China) with a conventional three-electrode system comprising of a modified glassy carbon electrode as the working electrode, a Pt counter electrode, and an Ag/AgCl reference electrode. Nanostructures were characterized by transmission electron microscopy (TEM, Hitachi 7700, Japan). Ultraviolet-vis absorption (UV-vis) spectra were recorded with a 1102 UV-vis spectrophotometer (Techcomp, China).
Synthesis of graphene nanostructures
Graphene nanostructures were prepared from natural graphite powder. 24 Briefly, graphite powder (2.0 g) was ground with NaCl to reduce the particle size. After removing the salt, the graphite was added to the concentrated H2SO4 (80 mL) and left under stirring for 2 h. Afterward, KMnO4 (10 g) was added gradually under stirring, and the temperature was kept to less than 20 C. Successively, the mixture was stirred at 35 C for 2 h. Keeping the temperature at less than 50 C, distilled water (180 mL) was added, the mixture was then stirred at room temperature (RT) for 3 h. The reaction was ended by a final addition of distilled water (450 mL) and H2O2 (30%, 20 mL). Consequently, the mixture was repeatedly washed with an aqueous HCl solution. Exfoliation was carried out by sonicating graphene nanostructures under ambient condition for 4 h. Finally, the suspension was centrifuged at 8000g for 10 min, and the obtained oupper solution was taken for future use.
Preparation of guanine and pAb antibody-functionalized graphene nanostructures
Guanine and pAb-functionalized graphene nanostructures (GGN-pAb) were prepared through classical carbodiimide coupling. Briefly, graphene nanostructures (2.76 mg) was initially dissolved in N-2-hydroxyethylpiperazine-N′-(2-ethanesulfonic acid) (0.7 mL, 50 mM, pH 9.3) buffer, and the pH of the resulted solution was then adjusted to pH 7.3 with 3.0 M HCl. NHS (11 mg) and EDC (15 mg) were dissolved in the mixture, followed continuous stirring for 60 min at RT. The mixture was centrifuged, and the obtained precipitation was redispersed into 1.0 mL PBS. Afterward, guanine (300 μL, 10 mM) and pAb (100 μL, 0.5 mg mL -1 ) were added into the mixture under continuous stirring at 150 rpm, and left at RT for 12 h. After completion of the incubation, the produced conjugates were dialyzed in a dialysis bag against PBS at RT for 24 h by changing the buffer every 6 h to remove the non-conjugated guanine and pAb. The obtained GGN-pAb conjugate was dispersed into 1.0 mL PBS and stored at 4 C for further use.
Preparation of electrochemical immunosensor
A glassy carbon electrode (GCE, 2 mm in diameter) was polished with 0.3 and 0.05 μm alumina, followed by successive sonication in distilled water and ethanol for 5 min and dried in air. After that, β-cyclodextrin (5 μL, 10 mM) was dropped on the surface of the cleaned GCE, and dried for 2 h at RT to form a CD-modified GCE. After washing with distilled water, mAb antibody (10 μL, 0.5 mg mL -1 ) was thrown onto the CD/GCE and incubated for 6 h at 4 C under humid conditions. During this process, mAb was immobilized onto the CD/GCE through host-guest chemistry. 25 Finally, the as-prepared mAb-CD-GCE was stored at 4 C when not in use.
Immunoassay protocol and electronic monitoring process
Scheme 1 represents the immunoassay protocol and electrochemical measurement process. The assay mainly consisted of two steps as follows: (i) Immunoreaction: Initially, 5 μL of NSE sample/standard solutions with various concentrations were dropped on the surface of mAb-CD-GCE and incubated for 25 min at RT. After washing with PBS, the resulting immunosensor was dipped into the prepared-above pAb-GGN colloids, and incubated for another 25 min at RT to form the sandwiched immunocomplex on the electrode. (ii) Electrochemical measurement: The electrochemical response of the immunosensor toward various-concentration NSE was monitored in 2 mL of pH 7.4 PBS containing 5 μM Ru(bpy)3 2+ by using differential pulse voltammetry (DPV; scanning range, 0.4 -1.5 V; amplitude, 50 mV; width, 50 ms). Analyses are always made in triplicate. All measurements were carried out at room temperature, unless otherwise stated.
Enzyme-linked immunosorbent assay (ELISA) for NSE
A commercially available ELISA kit was utilized for method comparison. In the sandwich ELISA with standard polystyrene 96-well plates, 50 μL of sample suspension was incubated at 37 C for 60 min; the wells were rinsed 3 times (3 min each) with 0.1 M PBS containing 0.5 M NaCl and 1.0 M Tween 20. Then 50 μL of conjugate solution was added and incubated for another 60 min. After washing, 50 μL of 3,3′,5,5′-tetramethylbenzidine (TMB) containing hydrogen peroxide was added and incubated at 37 C for 10 min. The enzymatic reaction was stopped by adding 50 μL of 2.0 M H2SO4 to each well. The results of ELISA were measured by a spectrophotometric ELISA reader at a wavelength of 450 nm.
Results and Discussion
Mechanism of pAb-GGN-based electrocatalyzed reaction
In this work, the detectable signal of the electrochemical immunoassay mainly derives from the immobilized guanines on the GGN and their catalytic oxidation in the presence of Ru(bpy)3
2+
. In the presence of target NSE, the sandwiched immunocomplex is formed between the immobilized mAb on the mAb-CD-GCE and pAb on the pAb-GGN. The amount of the sandwiched pAb-GGN increases with the increase of the NSE concentration in the sample, thereby resulting in an increase of the electrochemical signal.
With the sandwich-type immunoassay format, the antigenantibody complex is formed through a two-step reaction process as follows:
NSE/mAb-CD-GCE + pAb-GGN → GGN-pAb/NSE/mAb-CD-GCE.
The 
Ru(bpy)3 3+ + guanine → Ru(bpy)3 2+ + (guanine)ox.
During the electrocatalytic reaction, Ru(bpy)3 3+/2+ acts as a mediator, and facilitates an electron-transfer reaction between the immobilized guanine on the GGN and the based electrode. The mediator exhibits a reversible redox couple at +1.05 V, which is very similar to the oxidation potential of guanine. 27 Upon the addition of target NSE, the sandwiched immunocomplex can be formed between the mAb-CD-GCE and the pAb-GGN. The immobilized amount of guanine on the mAb-CD-GCE increases with the increase of the target NSE, thereby indirectly amplifying the detectable electrochemical signal. Figure 1A displays typical TEM image of graphene nanostructures. The morphology of the as-synthesized graphene nanostructures was planar sheet-like, indicating that the nanostructures were neither carbon nanotube nor graphite powder. Two sides of graphene nanosheets could be used as an immobilized affinity support for the conjugation of guanine and pAb. Such a planar nanostructure could provide a larger surface coverage in comparison with that of tubular or spherical nanostructures, thus conjugating more biomolecules.
Characterization of pAb-GGN conjugates
To verify the synthesis of pAb-GGN conjugates, UV-vis absorption spectroscopy has been employed to monitor the fabrication process. Curve a in Fig. 1B shows the spectrum of graphene nanostructures. A characteristic adsorption peak at 234 nm was observed at pure graphene nanostructures. After guanine was conjugated onto the graphene nanostructures, the adsorption peak shifted to 246 nm (curve b), which was ascribed to overlapping between the graphene nanostructure and guanine (253 nm). A further shift of the adsorption peak at 265 nm (curve c) was obtained after guanine and pAb antibody were simultaneously conjugated onto the graphene nanostructures. The reason might most likely be a consequence of the fact that the characteristic peak of pAb antibody (278 nm) was very close to that of GGN conjugations (246 nm, curve b). On the basis of the results, we might preliminarily conclude that guanine and pAb antibody could be conjugated onto the graphene nanostructures through the carbodiimide coupling.
Electrochemical characteristics of various electrodes
Electrochemical impedance spectroscopy (EIS) of ferricyanide is a valuable and convenient tool to monitor the barrier of modified electrode, because electron transfer between the solution species and the electrode must occur by tunneling either through the barrier or through defects in the barrier. 28 Therefore, it was chosen as a marker to investigate any changes of the electrode behavior after each assembly step. It is well known that the typical impedance spectrum consist of a semicircle portion and a linear portion. The semicircle portion at higher frequency corresponds to the electron-transfer-limited process, and the linear portion at lower frequency represents the diffusion process. 29 The semicircle diameter equals the electrontransfer resistance. variously modified electrodes in 5 mM Fe(CN)6 4-/3-containing 0.1 M KCl. It can be seen that the bare GCE exhibited a low resistance (curve a). After the electrode was modified with β-cyclodextrin, a relatively lower resistance was obtained for the redox probe (curve b), implying that β-cyclodextrin is an excellent electric conducting material and possess the ability of accelerating the electron transfer. It was found that after the CD/GCE was incubated with mAb antibody, the resistance increased (curve c), which might be attributed to the fact that mAb antibody is a kind of biomacromolecules and hinders the electron transfer.
To further investigate the bioactivity of the immobilized mAb on the electrode, the as-prepared mAb-CD-GCE was used for the reaction of 1.0 ng mL NSE. As can be seen from curve d in Fig. 2 , the resistance increased after the formation of immunocomplexes on the electrode, especially when the resulting electrode incubated again with pAb-GGN (curve e). The reason might be the fact that the sandwiched immunocomplex possessed weaker conductivity than that of the single antigen-antibody complex.
Electrocatalytic characteristic of pAb-GGN conjugates
To investigate the electrocatalytic capability of the as-prepared pAb-GGN conjugates toward Ru(bpy)3 2+ , we prepared two types of conjugates, with and without guanine (i.e. pAb-modified graphene nanostructures (pAb-GN) and pAb-GGN), which were directly immobilized onto two cleaned GCE electrodes, respectively. Following that, the resulting electrodes were monitored in PBS in the presence and absence of 5 μM Ru(bpy)3Cl2, respectively. As shown from curve a in Fig. 3 , the prepared pAb-GGN/GCE exhibited a weak electrochemical response in PBS, which was mainly derived from direct electron transfer of the conjugated guanine on the graphene nanostructures. Upon the addition of 5 μM Ru(bpy)3Cl2 in PBS, significantly, a strong catalytic current appeared (curve b in Fig. 3 ). In contrast, almost no peak current was observed at pAb-GN/GCE in PBS, regardless of whether Ru(bpy)3Cl2 was present (inset of Fig. 3) . The results revealed that the catalytic current originated from the conjugated guanine. The signal amplification mainly derives from the following issues: (i) Ru(bpy)3 3+ has the close reduction potential with guanine radical cation, and (ii) the second-order rate constant for electron transfer from guanine to Ru(bpy)3 3+/2+ is as high as 10 6 M -1 S -1 .
Optimization of experimental conditions
To achieve an optimal analytical performance of the developed immunoassay, some experimental parameters, including incubation time and incubation temperature for the antigen-antibody reaction, should be investigated. Considering the possible application of the developed immunoassay in the future, we selected room temperature (25 + 1.0 C) for the antigen-antibody interaction throughout the experiment. Under this condition, we monitored the effect of the incubation time on the current of the immunosensor (Note: To avoid confusion, the incubation time of the immunosensor with NSE was paralleled with that of the immunosensor-NSE with pAb-GGN). As shown in Fig. 4a , the current increased with the increment of the incubation time, and tended to level off after 25 min. Hence, an incubation time of 25 min was selected for the sensitive determination of NSE at qn acceptable throughput.
Owing to the co-immobilization of guanine and pAb on the graphene nanosheets, the conjugated ratio of guanine and pAb is one of the most important factors influencing the sensitivity of the electrochemical immunoassay. Usually, a highly carried amount of pAb antibody on the graphene nanosheets can increase the possibility of the antigen-antibody reaction, but it is not conducive to the electrocatalytic reaction. As shown in Fig. 4b , the optimal current was obtained at a volume ratio of 3:1 between guanine and pAb. Thus, guanine (300 μL, 10 mM) and pAb (100 μL, 0.5 mg mL -1 ) were used for preparation of pAb-GGN.
Analytical performance
It is well known that highly sensitive detection of low-abundance protein is very important for early cancer diagnosis to increase the chance for effective treatment. In this study, the sensitivity and dynamic range of the electrochemical immunoassay were evaluated toward the NSE standard in PBS containing 5 μM Ru(bpy)3 2+ under optimal conditions, using pAb-GGN as molecular tags on the mAb-CD-GCE. Experimental results indicated that the DPV peak currents of the immunosensor increased with the increasing NSE concentration, and exhibited a wide dynamic range of 0.005 -80 ng mL -1 with a low detection limit of 1.0 pg mL -1 NSE at a signal-to-noise ratio of 3σ (where σ is the standard deviation of the blank, n = 13) (Fig. 5) .
The linear regression equation is ipc (μA) = 0.3628 × log C[NSE] (ng mL -1 ) + 2.2143 (R 2 = 0.9893, n = 18). Since the threshold value of the NSE sample in normal human serum is 12.5 mg L -1 , the developed immunosensor could meet the need of practical application in clinical immunoassay. Although the system has not yet been optimized for maximum efficiency, the LOD of using pAb-GGN was over 390-fold lower than that of commercially available human NSE ELISA kit (0.39 ng mL -1 NSE, CusaBio Biotech. Inc.). The reproducibility and precision of the electrochemical immunoassay were evaluated by calculating intra-and inter-assay coefficient of variation (CV). We repeatedly assayed three different NSE levels containing 1.0 pg mL -1 , 0.1 ng mL -1 , and 30 ng mL -1 under the same conditions. Experimental results revealed that the coefficients of variation (CVs) of inter-assay were 3.7, 6.7, and 5.2% for 1.0 pg mL -1 , 0.1 ng mL -1 , and 30 ng mL -1 NSE, respectively, whereas the CVs of the intra-assay were 9.3, 7.7 and 9.5% towards the above-mentioned analytes. Therefore, the precision and reproducibility of the developed immunosensor was acceptable. To evaluate the specificity of the electrochemical immunoassay, we challenged the system with other proteins or biomarkers, such as cancer antigen 125 (CA 125), alpha-fetoprotein (AFP), prostate-specific antigen (PSA) and BSA. The current response for target NSE was 3-fold increased at a concentration level of three orders of magnitude lower than that of the other antigens (Fig. 6) . These results clearly indicated the high specificity of the electrochemical immunoassay.
Analysis of real samples
To further elucidate the analytical reliability and applicable potential of the developed immunoassay, NSE standards with various concentrations were spiked into blank new-born cattle serum, which were assayed by using the developed immunoassay and a referenced ELISA method, respectively. The results are listed in Table 1 . As shown from Table 1 , the relative standard deviation (RSD) values between two methods were lower than 7.0%. Therefore, the developed electrochemical immunoassay could be regarded as being an optional scheme for the determination of NSE in clinical diagnostics.
Conclusions
In summary, this work has produced a new and enzyme-free immunoassay protocol for the sensitive electrochemical monitoring of neuron-specific enolase (as a mode protein) by using guanine-decorated graphene nanostructures as nanotags. The signal is achieved by catalytic oxidation of the conjugated guanine on the graphene nanostructures in the presence of Ru(bpy)3
2+
. The highlight of this study is to employ the catalytic oxidation system of the biomolecules by using an inorganic metal complex as the oxidation catalyst, and to avoid the participation of bioactive enzyme. Meanwhile, the methodology can avoid the use of two working electrodes or multiple enzymes for amplification of the electrochemical signal. Compared with enzyme-based immunoassays, the enzyme-free electrocatalytic immunoassay is low-cost, simple, and feasible. 
